Business Wire

CES 2017: Center Stage for the 5G Revolution

Del

CES® 2017 is the world’s largest show for connectivity. The entire global technology ecosystem will gather to showcase the revolutionary impact 5G, the next generation of mobile network technology, will have on connectivity and mobility across every major business sector. The future of 5G and its effect on the connected world will be a major focus at CES 2017, highlighted by the SuperSession, “Stoked About 5G,” presented by Ericsson. Owned and produced by the Consumer Technology Association (CTA)TM, CES 2017 is scheduled January 5-8, in Las Vegas, Nevada.

“From the Internet of Things, to virtual reality to self-driving cars and beyond, connectivity is at the core of emerging innovation. With the entire spectrum of technology on display, there is no better place to experience the 5G revolution than at CES 2017,” said Gary Shapiro, president and CEO, CTA. “Ericsson’s SuperSession will paint a picture of our new connected world with 5G technology, including new products and services that will revolutionize the way consumers live, work and play. With more than 3,800 exhibiting companies across 24 product categories, the true impact of connectivity will be unveiled at CES 2017.”

The “Stoked About 5G” SuperSession presented by Ericsson will take place at 10:15 AM, Thursday, January 5 in the LVCC, North Hall, Room N257. The session will explore the bright future of mobility with 5G, the network that reacts faster than the human brain. Speakers include:

  • Hanno Basse, CTO, 20th Century Fox Film Corp.
  • Alex Choi, CTO, EVP and Head of Corporate R&D Center, SK Telecom
  • Dr. Fathi El-Dwaik, Vice President, Information and Communication Electronics, BMW Group
  • Ulf Ewaldsson, Sr. VP, Chief Strategy and Technology Officer, Ericsson Inc.
  • Ina Fried, Senior Editor, Re/code (Moderator)

Connectivity will be ubiquitous throughout CES 2017, touching nearly every product category from automotive to smart home, robotics, fitness tech, health and wellness, wearables and more. In addition, the CES Conference Program will highlight the latest developments in connected mobility with topics including Self Driving Technology, IoT, Smart Cities, Digital Health and 5G, as well as a keynote from Qualcomm CEO Steve Mollenkopf, who will discuss the worldwide impact of 5G.

In addition to Ericsson, leaders in connectivity and mobility will be at CES launching new products and services such as: Huawei, Qualcomm, Sprint, Verizon, Samsung, LG, TCL, ZTE Blackberry, Nokia and more. 5G will open up an explosion of new services – including broadband and better home services, faster connectivity for smart cars, affordable smart city infrastructure and interactive AR/VR experiences. With the full spectrum of technology on display, CES 2017 will illustrate how 5G will truly benefit consumers.

Visit CES.tech for the latest news and announcements or to register for CES 2017.

Note to Editors: The official name of the global technology event is “CES ® .” Please do not use “Consumer Electronics Show” or “International CES” to refer to the event.

Please note updated CES security measures on CES.tech , including bag check points, bag restrictions and exceptions and badge pickup locations for CES 2017.

About CES:

CES is the world’s gathering place for all who thrive on the business of consumer technologies. It has served as the proving ground for innovators and breakthrough technologies for 50 years—the global stage where next-generation innovations are introduced to the marketplace. As the largest hands-on event of its kind, CES features all aspects of the industry. Owned and produced by the Consumer Technology Association (CTA)TM, it attracts the world’s business leaders and pioneering thinkers. Check out CES video highlights. Follow CES online at CES.tech and on social.

About Consumer Technology Association:

Consumer Technology Association (CTA)TM, is the trade association representing the $287 billion U.S. consumer technology industry. More than 2,200 companies – 80 percent are small businesses and startups; others are among the world’s best known brands – enjoy the benefits of CTA membership including policy advocacy, market research, technical education, industry promotion, standards development and the fostering of business and strategic relationships. The Consumer Technology Association also owns and produces CES® – the world’s gathering place for all who thrive on the business of consumer technologies. Profits from CES are reinvested into CTA’s industry services.

UPCOMING EVENTS

  • CES Unveiled Las Vegas
    January 3, Las Vegas, NV
  • CES 2017 – Register
    January 5-8, Las Vegas, NV
  • Winter Break
    March 9-12, Snowmass, CO
  • Digital Patriots Dinner
    April 4, Washington, DC
  • CES on the Hill
    April 5, Washington, DC
  • CES Asia 2017
    June 7-9, Shanghai, China
  • CEO Summit
    June 21-24, Amalfi Coast, Italy

Contact information

Consumer Technology Association
Allison Fried, 703-907-7603
afried@CTA.tech
www.CTA.tech
or
Sarah Brown, 703-907-4326
sbrown@CTA.tech
www.CES.tech

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program12.12.2017 15:23Pressemelding

Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today released its latest Scientific Update for Smoke-Free Products, a regular publication on its research efforts to develop and assess a range of smoke-free alternatives to cigarettes. The latest issue of the Scientific Update can be found at this link. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005891/en/ Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program (Photo: Business Wire) This issue of the Scientific Update provides a closer look at some of the principles and practices on which PMI’s scientific assessment program is built. Director Medical Affairs Dr. Patrick Picavet describes specific examples from PMI’s clinical program that highlight the company’s

Murex to Offer MX.3 Risk, Trading and Post-Trade Solutions on the AWS Cloud12.12.2017 14:00Pressemelding

Murex, an industry leader in trading, risk management and processing solutions for capital markets, announced they will run their MX.3 technology platform on Amazon Web Services, Inc. (AWS). With the acceleration of cloud adoption in capital markets, Murex and AWS agreed to collaborate to help clients migrate their Murex application workloads to the AWS Cloud. Murex clients are looking to consolidate more and more of their capital markets activity on the MX.3 platform and this means their need for infrastructure is increasing. New regulatory requirements are also driving financial organizations to use cloud to scale up their computing capacity. Murex is collaborating with AWS to meet the demand from clients to support deployment of the Murex offering on the AWS Cloud. Murex is working on the validation of a range of deployment scenarios, from using AWS Cloud for bursting grid

Darzalex®▼(daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible12.12.2017 13:33Pressemelding

Janssen-Cilag International NV (“Janssen”) today announced data from the Phase 3 ALCYONE study, showing Darzalex® (daratumumab) in combination with bortezomib, melphalan and prednisone (VMP) significantly improved clinical outcomes, including reducing the risk of disease progression or death by 50 percent, in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation (ASCT).1 These data were accepted as a late-breaking abstract (LBA) for presentation at the 59th American Society of Hematology (ASH) Annual Meeting in Atlanta, today at 7:30 a.m. ET (Abstract #LBA-4).1 Study findings were simultaneously published in the New England Journal of Medicine (NEJM) . 2 Daratumumab is currently indicated for use in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for

CTS Engines Announces Senior Management Hire12.12.2017 13:00Pressemelding

CTS Engines, the global leader for mature jet engine maintenance, announced today that it had hired Diane E. Cavuoto as Senior Vice President, Supply Chain, in an effort to continue to provide its customers with outstanding engine overhaul services. Ms. Cavuoto will be based in CTS’s Ft. Lauderdale headquarters and will report directly to Vesa Paukkeri, CTS’s President and Chief Operating Officer. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005050/en/ Diane E. Cavuoto, Senior Vice President, Supply Chain, for CTS Engines (Photo: Business Wire) Ms. Cavuoto, most recently Vice President, Strategic Sourcing at Honeywell International, brings years of supply chain management experience to CTS. In her prior role at Honeywell, Ms. Cavuoto managed a global commodity team of 150 employees managing $4

MIPI Alliance Opens Access to its MIPI I3C Sensor Interface Specification12.12.2017 13:00Pressemelding

The MIPI® Alliance, an international organization that develops interface specifications for mobile and mobile-influenced industries, today announced it is opening access to its sensor interface specification, MIPI I3C. Starting today, all companies, including those not currently members of MIPI Alliance, may access the MIPI I3C v1.0 specification so they may evaluate the incorporation of the specification into their sensor integration plans and design applications. “MIPI I3C provides a welcome update to the I2C technology that has been widely adopted over the past 35 years. Extending access provides an opportunity to spur innovation and help other industries beyond mobile," said Joel Huloux, chairman of MIPI Alliance. "It helps MIPI members as well, because it supports greater adoption and interoperability, strengthens the ecosystem and provides for a richer

ADC Therapeutics Announces Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-30112.12.2017 11:23Pressemelding

ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers, today announced clinical data from two ongoing Phase I clinical trials evaluating ADCT-301 (camidanlumab tesirine or “Cami-T”) in important subtypes of lymphoma and leukemia. The data were presented at the 59th American Society of Hematology (ASH) Annual Meeting in Atlanta, USA. 1. Interim results of a Phase I open label, single agent, dose-escalating study of ADCT-301 evaluating tolerability, safety, pharmacokinetics and efficacy in patients with relapsed or refractory B-cell Hodgkin’s or non-Hodgkin’s lymphoma Dr. Steven M. Horwitz, Medical Oncologist at Memorial Sloan Kettering Cancer Center in New York City, and Principal Investigator, s

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom